Original Article

Dermatoglyphics of Women With Systemic Arterial Hypertension

Abstract

Systemic arterial hypertension is a clinical condition of great risk in the development of cardiovascular diseases and it has a high impact on public health. The disease is influenced by modifiable and non-modifiable factors. In that context, Dermatoglyphics is a method of analysis of fingerprints as a mark of biological individuality and that can be related to health, sports, and the prognosis of diseases due to being able to point out the individual with the potential to develop certain diseases. This study aimed to investigate the characteristics of the fingerprints of women with systemic arterial hypertension by comparing them with a control group, which does not present the disease. Thus, we intend to find a dermatoglyphic pattern for Brazilian women with systemic arterial hypertension. The sample in the study consisted of 732 women, 366 with a positive clinical diagnosis for systemic arterial hypertension, and 366 individuals forming a control group, which did not present systemic arterial hypertension. All individuals in the sample are of equivalent age and the fingerprints were collected from all fingers. The method used to determine the profile of the individuals is the computerized dermatoglyphic. It was used, for the collection of fingerprints, of the Dermatoglyphic Reader®, which presents results of 400% more precision. There was a statistically significant difference between the groups, and when the Adjusted Residue Analysis was performed, the Ulnar Loop figure on fingers 4 and 5 of the left hand, and fingers 1 and 5 of the right hand, was predominant in the group of women with hypertension. These results demonstrate the existence of a dermatoglyphic mark, characteristic of patients with systemic arterial hypertension. Therefore, it can be concluded that the analysis of fingerprints of the hands by the Dermatoglyphic method can demonstrate the potential that women could have developing systemic arterial hypertension.

1. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Nefrologia. VI Brazilian Guidelines on Hypertension. Arq Bras Cardiol 2010;95:1-51.
2. WORLD HEALTH ORGANIZATION. Mortality and burden of disease. Noncommunicable Diseases (NCD) Country Profiles, 2014.
3. de Carvalho T, Milani M, Ferraz AS, da Silveira AD, Herdy AH, Hossri CA, et al. Diretriz de reabilitação cardiopulmonar e metabólica: aspectos práticos e responsabilidades. Arq Bras Cardiol 2016;86.
4. Kilic M, Ede H, Yildirim T. The effect of risk factors on the prevalence, awareness and control of hypertension: a multiple logistic regression analysis. Acta Med Mediterr 2015;31:1285-90.
5. Martin-Llaguno M, Alvarez-Dardet C. The genome alibi project: Towards a genetic reductionism? J Epidemiol Community Health 2000;54:641.
6. NODARI JUNIOR, R. J.; FIN, G. Dermatoglyphic: Fingerprints as a marker gene and embryo development. Sallus Dermatoglifia, 2016.
7. Vucetich M, Laguens R, Bearzi V, Benzecry LI. Histochemical aspects of the human endometrium. Obstet Ginecol Lat Am 1957;15:236-9.
8. Cummins HE, Midlo CH. Finger Prints, Palms and Soles an Introduction to Dermatoglyphics. New York: Dover Publications, inc, 1961.
9. BRASIL. Ministério da Saúde. Instituto Brasileiro de Geografia e Estatística. Fiocruz. Pesquisa Nacional em Saúde 2013: Percepção do estado de saúde, estilos de vida e doenças crônicas Brasil, Grandes Regiões e Unidades da Federação. Rio de Janeiro: IBGE, 2014.
10. Brunoni D. Aconselhamento Genético. Ciênc. Saúde Coletiva 2002;7.
11. Simao AF, Precoma DB, Andrade JP, Correa Filho H, Saraiva JFK, Oliveira GMM, et al. Sociedade Brasileira de Cardiologia. I Diretriz Brasileira de Prevenção Cardiovascular. Arq Bras Cardiol 2013:101:1-63.
12. Nodari Junior RJ, Heberle A, Ferreira-Emygdio R, Irany-Knackfuss M. Impressões Digitais para Diagnóstico em Saúde: validação de Protótipo de Escaneamento Informatizado. Rev salud publica 2008;10:767-76.
13. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Secretaria de Gestão Estratégica e Participativa. Vigitel Brasil 2009: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico/Ministério da Saúde, Secretaria de Vigilância em Saúde, Secretaria de Gestão Estratégica e Participativa. – Brasília : Ministério da Saúde, 2010.
14. Oliveira SMJV, Santos JLF, LebrãoIII ML, Oliveira Duarte YA, Pierin AMG. Hipertensão arterial referida em mulheres idosas: prevalência e fatores associados. Texto Contexto Enferm 2008;17:241-9.
15. Wijerathne BT, Meier RJ, Agampodi TC, Agampodi SB. Dermatoglyphics in hypertension: a review. J Physiol Anthropol 2015;34:29.
16. Kulkarni SKG, Avinash SS, Sreekantha V. Dermatoglyphics in primary hypertensive patients. Int J Pharma Bio Sci 2014;5:53-8.
17. Kachhave SK, Solanke PV, Mahajan AA, Rao SS. Dermatoglyphics in the essential hypertension in Marathwada region. Indian J Public Heal Res Dev 2013;4:194-8.
18. Franklin SS, Gustin 4th W, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-15.
19. Ciccarelli M, Finelli R, Rivera N, Santulli G, Izzo R, De Luca N, at al. The possible role of chromossome X variability in hypertensive familiarity. J Hum Hypertens 2017;31:37-42.
20. Bulagouda RS, Patil PJ, Hadimani GA, Bannur BM, Patil BG, et al. Study of palmar dermatoglyphics in patients with essential hypertension between the age group of 20–50 years. Int J Med Res Heal Sci 2013;2:773-9.
21. Tafazoli M, Dezfooli S, Kazemi T, Mahdavi Shahri H. Comparison of dermatoglyphic patterns between healthy and hypertensive people. Asian J Med Sci 2013;5:19-25.
22. Deepa G. Study of palmar dermatoglyphics in essential hypertension. Natl J Integr Res Med 2013;4:61-5.
23. Godfrey KM, Barker DJ, Peace J, Cloke J, Osmond C. Relation of fingerprints and shape of the palm to fetal growth and adult blood pressure. BMJ 1993;307:405-9.
24. Dipierri JE, Gutiérrez-Redomero E, Alonso-Rodríguez C, Alfaro E, Demarchi D, Rivaldería N. Surnames geographic altitude, and digital dermatoglyphics in a male population from the province of Jujuy (Argentina). Homo 2014;65:256-66.
25. Yohannes S, Bekele E. Ethiopian Population Dermatoglyphic Study Reveals Linguistic Stratification of Diversity. PLoS One 2015;10:e0126897.
26. Zhang HG, Chen YF, Ding M, Jin L, Case DT, Jiao YP, et al. Dermatoglyphics from All Chinese Ethnic Groups Reveal Geographic Patterning. PLoS One 2010;5:e8783.
27. Alberti A, Traebert J, Traebert E, Nodari Junior RJ , Comim CM. Association between gestational period and obesity in children with the use of dermatoglyphic traits: A preliminary study. PLoS One 2021;16:e0257153.
Files
IssueVol 61 No 7 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/acta.v61i7.14493
Keywords
Hypertension Dermatoglyphics Prognosis Prevention
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Sartori G, Pertille F, Alberti A, Becker da Silva B, Dallacosta F, Fin G, Souza R, Comim C, Nodari Júnior R. Dermatoglyphics of Women With Systemic Arterial Hypertension. Acta Med Iran. 2023;61(7):386-393.